NASDAQ:PRCT

Procept Biorobotics Stock News

Healthcare > Medical - Devices

Buy PRCT

*Your capital is at risk

$16.69

-0.86 (-4.90%)

At Close: Jul 24, 2026

From Science Fiction to Reality: 3 Robotics Stocks for Automatic Riches

06:00am, Tuesday, 14'th May 2024

Robotics stocks should be a leading investment theme throughout the 2020s. The concept of automating factories, warehouses and data entry work has long appealed to large corporations.

PROCEPT BioRobotics to Present at Upcoming 2024 Leerink Partners Healthcare Crossroads Conference and 44th Annual William Blair Growth Stock Conference

04:05pm, Monday, 13'th May 2024

SAN JOSE, Calif., May 13, 2024 (GLOBE NEWSWIRE) -- PROCEPT BioRobotics® (Nasdaq: PRCT) (the “Company”), a surgical robotics company focused on advancing patient care by developing transformative

Real-World, Long-Term Data Demonstrate Sustained Benefits of Aquablation Therapy for Men with Benign Prostatic Hyperplasia

08:00am, Monday, 06'th May 2024

Data from the Icahn School of Medicine at Mount Sinai and Potomac Urology presented at the 2024 AUA Annual Meeting highlight Aquablation therapy's potential to become the new standard of care in BPH f

PROCEPT BioRobotics Corporation (PRCT) Q1 2024 Earnings Call Transcript

12:56pm, Wednesday, 01'st May 2024

PROCEPT BioRobotics Corporation (NASDAQ:PRCT ) Q1 2024 Earnings Conference Call May 1, 2024 9:00 AM ET Company Participants Matt Basco - Vice President, Investor Relations Reza Zadno - Chief Executive

Biotech Leader Procept BioRobotics Jumps Past Buy Point On Earnings

09:29am, Wednesday, 01'st May 2024

Procept Stock: Biotech leader Procept BioRobotics is breaking out past its latest buy point. Shares jumped on Q1 earnings results Wednesday.

PROCEPT BioRobotics Corporation (PRCT) Reports Q1 Loss, Tops Revenue Estimates

09:26am, Wednesday, 01'st May 2024

PROCEPT BioRobotics Corporation (PRCT) came out with a quarterly loss of $0.51 per share versus the Zacks Consensus Estimate of a loss of $0.55. This compares to loss of $0.63 per share a year ago.

PROCEPT BioRobotics Reports First Quarter 2024 Financial Results and Increases 2024 Revenue Guidance

07:00am, Wednesday, 01'st May 2024

SAN JOSE, Calif., May 01, 2024 (GLOBE NEWSWIRE) -- PROCEPT BioRobotics® Corporation (Nasdaq: PRCT) (the “Company”), a surgical robotics company focused on advancing patient care by developing tra

PROCEPT BioRobotics Announces 12 Scientific Research Presentations on Aquablation Therapy for the Treatment of Benign Prostatic Hyperplasia at the 2024 AUA Annual Meeting

08:00am, Tuesday, 23'rd Apr 2024

Presentations include first published experience report of same-day discharge in an ambulatory surgical center, real-world data outcomes and 5-year data comparison between two FDA trials Presentations

PROCEPT BioRobotics Corp. Announces Investor Event at 2024 AUA Annual Meeting in San Antonio, Texas

04:04pm, Thursday, 04'th Apr 2024

SAN JOSE, Calif., April 04, 2024 (GLOBE NEWSWIRE) -- PROCEPT BioRobotics® Corporation (Nasdaq: PRCT), a surgical robotics company focused on advancing patient care by developing transformative solut

PROCEPT BioRobotics to Report First Quarter 2024 Financial Results on May 1, 2024 and Attend the 2024 Bank of America Healthcare Conference on May 15, 2024

04:03pm, Tuesday, 02'nd Apr 2024

SAN JOSE, Calif., April 02, 2024 (GLOBE NEWSWIRE) -- PROCEPT BioRobotics® Corporation (the “Company”) (Nasdaq: PRCT), a surgical robotics company focused on advancing patient care by developing t

Top Fintech Company

featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by